Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients
JAMA
.
2022 Jan 11;327(2):124-125.
doi: 10.1001/jama.2021.21890.
Authors
Benoît Mâsse
1
2
,
Nancy Robitaille
3
4
5
,
Jacques Lacroix
3
4
Affiliations
1
Université de Montréal, Montreal, Quebec, Canada.
2
Unité de Recherche Clinique Appliquée, Direction de la Recherche, CHU Sainte-Justine, Montreal, Quebec, Canada.
3
Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
4
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
5
Transfusion Medicine, Héma-Québec, Montreal, Quebec, Canada.
PMID:
35015051
DOI:
10.1001/jama.2021.21890
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants / adverse effects
Child
Humans
Secondary Prevention
Venous Thromboembolism* / drug therapy
Venous Thrombosis*
Substances
Anticoagulants